Page last updated: 2024-08-24

6-sulfatoxymelatonin and Down Syndrome

6-sulfatoxymelatonin has been researched along with Down Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corrales, A; Flórez, J; García, E; García, S; Martínez, P; Martínez-Cué, C; Rueda, N; Sanchez-Barceló, EJ; Vidal, V1
Barlow-Walden, L; Clayton, RJ; Heiden, SM; Poeggeler, B; Reiter, RJ1

Other Studies

2 other study(ies) available for 6-sulfatoxymelatonin and Down Syndrome

ArticleYear
Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome.
    Journal of pineal research, 2013, Volume: 54, Issue:3

    Topics: Administration, Oral; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Behavior, Animal; Cerebral Cortex; Disease Models, Animal; Down Syndrome; Drug Administration Schedule; Female; Hippocampus; Male; Maze Learning; Melatonin; Mice; Nerve Degeneration

2013
Twenty-four hour urinary excretion of 6-hydroxymelatonin sulfate in Down syndrome subjects.
    Journal of pineal research, 1996, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Child; Child, Preschool; Circadian Rhythm; Darkness; Down Syndrome; Female; Humans; Light; Male; Melatonin; Middle Aged

1996